Simple Summary Liver functional failure is one of the leading causes of cancer-related
death. Systemic chemotherapy usually offers a modest benefit in terms of disease control …

Background: Hepatic arterial infusion chemotherapy (HAIC) is one option for treating
massive tumors and unresectable hepatocellular carcinoma (HCC). However, there is a lack …

Primary hepatobiliary cancers (PHCs), which mainly include hepatocellular carcinoma
(HCC) and biliary tract cancers (BTCs), are mostly diagnosed in the advanced stage and are …

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Surgery,
percutaneous ablation and liver transplantation are the only curative treatment modalities for …

Abstract Treatment of advanced hepatocellular carcinoma (HCC) remains a significant
problem for clinicians. Sorafenib, the only approved agent, improves survival rate, but is …

The technique of hepatic arterial infusion (HAI) for the treatment of liver metastases from
colorectal cancer has been developed over more than 30 years. Although the indications …

Recently, treatments for unresectable hepatocellular carcinoma (HCC) have undergone
remarkable development. Various systemic chemotherapy drugs have been approved and …

Hepatic arterial infusional (HAI) chemotherapy is based on the premise that primary and
metastatic tumors derive their blood supply from the hepatic artery, whereas normal liver …

Background: Hepatic arterial infusion chemotherapy (HAIC) is frequently used to treat
advanced hepatocellular carcinoma (HCC) in Asian countries. However, there is a lack of …

Purpose Hepatic arterial infusion chemotherapy (HAIC) has been reported to be effective in
patients with advanced hepatocellular carcinoma (HCC). Methods In this multicenter …